Axonics announces two-year results from its ARTISAN-SNM study
Two-year results of Axonics’ ARTISAN-sacral neuromodulation (SNM) study demonstrate that patients implanted with the r-SNM system continue to receive clinically meaningful and statistically significant...
Synchron secures funding to advance commercialisation of Stentrode
Synchron has been awarded nearly AUD$1M ($990,000) in funding from the Medical Research Future Fund (MRFF), through MTPConnect, the Australian Government’s BioMedTech Horizons (BMTH)...
FDA approves Abbott’s iOS-compatible app for the management of chronic pain and movement disorders
Abbott announces it has received approval from the US Food and Drug Administration (FDA) for the use of its Patient Controller app on compatible...
Asleep surgery improves the therapeutic window for deep brain stimulation
Evidence in support of the motion that asleep surgery improves the therapeutic window for deep brain stimulation (DBS) when compared to awake surgery, has...
